{"id":229099,"title":"Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T00:18:11.745000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/inhalers/release-final-guidance-document-data-requirements-safety-effectiveness-subsequent-market-entry-steroid-nasal-products-use-treatment-allergic-rhinitis.html?wbdisable=false","snippet":"Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search…","rawSnapshotUrl":"/api/snapshots/raw/229099","browseUrl":"https://replay.healtharchive.ca/job-1/20250419001811/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/inhalers/release-final-guidance-document-data-requirements-safety-effectiveness-subsequent-market-entry-steroid-nasal-products-use-treatment-allergic-rhinitis.html?wbdisable=false#ha_snapshot=229099","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}